Methyl-1,2,4-Triazolo[3,4-B]Benzo-1,3-Thiazole

Low-Temperature Amidation Routes to Triazole Antifungal APIs

In cGMP intermediate manufacturing for systemic triazole antifungals, methyl-1,2,4-triazolo[3,4-b]benzo-1,3-thiazole functions as a heterocyclic core that undergoes regioselective N-acylation with (2R,3R)-3-(2,4-difluorophenyl)-3-hydroxy-2-methylpropanoyl chloride at a controlled stoichiometric ratio of 1:1.02 (freebase:acyl chloride) in anhydrous dichloromethane containing 1.2 equivalents of triethylamine. The exothermic amidation is conducted in a 2000 L glass-lined reactor equipped with a brine-cooled jacket capable of maintaining an internal temperature of -5 °C to 0 °C; excursions above +2 °C promote epimerization at the α-carbon of the acyl donor and generate a diastereomeric impurity that co-elutes with the desired (R,R)-stereoisomer on Kromasil C18 analytical columns (USP L1, 250 × 4.6 mm, 5 µm). Post-reaction, the organic layer is washed with 5% w/v sodium bicarbonate solution until the aqueous phase reaches pH 7.2–7.5, dried over anhydrous sodium sulfate, and concentrated under vacuum (≤50 mbar, jacket temperature ≤35 °C) to avoid thermal degradation of the newly formed amide bond. The crude product is recrystallized from 2-propanol:n-heptane (3:1 v/v), yielding a crystalline solid with a melting point of 168–170 °C and an HPLC purity exceeding 99.5 area%. Residual solvent panels must comply with ICH Q3C Option 2 limits; in routine production, headspace GC-FID analysis demonstrates dichloromethane residuals below 600 ppm and 2-propanol below 5000 ppm. The isolated intermediate is subsequently deprotected and sulfonylated to form the final posaconazole or ravuconazole precursor. A typical batch-to-batch potency variance on 150 kg scale remains within 0.3% when the crystallization cooling ramp is controlled at 0.2 °C/min from 60 °C to 5 °C.

Experience from multiple contract manufacturing organizations indicates that the main scaling bottleneck arises during the solvent swap from dichloromethane to dimethylformamide for the subsequent nucleophilic substitution. If residual dichloromethane exceeds 0.1% v/v in DMF, the reaction with 1,2,4-triazole generates intractable tars that foul the overhead condenser and lower yield by 12–18%. Mitigation requires a wiped-film evaporator (Pfaudler WFE, heated surface area 0.5 m², jacket temperature 40 °C, rotor speed 300 rpm) operating under 10–15 mbar vacuum to reduce dichloromethane below detection limit. The entire sequence must be executed under a nitrogen atmosphere with oxygen levels monitored at <0.5% v/v to prevent oxidative dimerization of the triazole-thiazole skeleton. Documentation adhering to FDA 21 CFR Part 211 subpart J is mandatory; batch records include in-process controls for water content (Karl Fischer, limit ≤0.05%) before the acylation step.

When evaluating a new supplier of methyl-1,2,4-triazolo[3,4-b]benzo-1,3-thiazole for API applications, residual heavy metal profiles are scrutinized. ICP-MS analysis must confirm palladium and copper levels below 10 ppm each, as these metals derive from the catalytic hydrogenation or Ullmann-type coupling used to construct the fused ring system. Palladium contamination at even 25 ppm has been observed to catalyze decomposition of the final antifungal triazole during accelerated stability testing at 40 °C/75% RH, with degradation products exceeding the ICH Q3B qualification threshold after four weeks.

What Limits This Heterocycle’s Potency in Agricultural Suspension Concentrates?

Development of triazolo-benzothiazole derivatives for cereal fungicide formulations—structural analogues of prothioconazole-desthio—favors a methyl substitution pattern that maintains systemic mobility while reducing acute mammalian toxicity. The active ingredient is synthesized by condensing the methyl-1,2,4-triazolo[3,4-b]benzo-1,3-thiazole core with a chloromethyl ketone intermediate in refluxing acetonitrile (82 °C) in the presence of potassium carbonate (1.5 equivalents) and catalytic tetrabutylammonium bromide (0.05 equivalents). The heterogeneous reaction mixture requires vigorous agitation at 350–400 rpm in a 5000 L reactor with a pitched-blade turbine to maintain solids suspension; insufficient mixing causes the potassium carbonate to form a dense cake layer that inhibits mass transfer and extends reaction time from 8 hours to over 24 hours. After filtration through a plate filter press coated with Celite 545, the acetonitrile mother liquor is distilled under 100 mbar vacuum and replaced with methanol for crystallization. The technical-grade material typically assays at 95–97% and still contains a des-chloro byproduct that acts as a crystal growth inhibitor during suspension concentrate (SC) formulation.

Formulation into a 480 g/L SC requires wet grinding in a horizontal bead mill (WAB Dyno-Mill KD, chamber volume 6.0 L, 80% loading with 0.8–1.0 mm yttria-stabilized zirconia beads) with an aqueous phase containing 2.5% w/w sodium lignosulfonate (Borresperse NA), 1.0% w/w naphthalene sulfonate condensate (Galoryl DT 201), 0.2% w/w xanthan gum thickener (Rhodopol 23), and 0.05% w/w biocide (1,2-benzisothiazolin-3-one). Particle size distribution (Malvern Mastersizer 3000) after three passes typically yields D50 1.8 µm and D90 5.2 µm. Notably, if the grinding temperature exceeds 45 °C, crystal growth upon storage at 54 °C for 14 days (accelerated storage per CIPAC MT 46.3) results in visible sedimentation and a hard-packed layer that cannot be resuspended with 10 inversions. This phenomenon is attributed to Ostwald ripening driven by the des-chloro impurity; its concentration must be held below 1.2% in the technical material to pass the wet sieve retention test on a 75 µm mesh (≤0.5% residue).

Regulatory compliance under EU Regulation (EC) No 1107/2009 requires a five-batch analysis for relevant impurities and confirmatory toxicity studies on the formulated product. Acute oral LD50 in rats (OECD 423) typically falls between 2000–5000 mg/kg bw; the Material Safety Data Sheet must indicate Aquatic Chronic 2 (H411) classification if the 96-hour LC50 for Oncorhynchus mykiss is below 10 mg/L. In-situ tank-mix compatibility with prothioconazole and tebuconazole SCs has been verified with no phase separation or flocculation in CIPAC MT 178 test.

In contrast to the pharmaceutical-grade amidation described earlier, the agricultural intermediate tolerates a broader impurity profile. Iron content up to 50 ppm originating from carbon steel reactors does not adversely affect fungicidal performance, although values above 100 ppm catalyze photolytic degradation when the SC is applied to leaf surfaces under full-spectrum sunlight (UV-A intensity ≥4.5 mW/cm²).

Compounding into a TPO formulation (nominal melt flow rate 0.8 g/10 min at 230 °C/2.16 kg, ISO 1133-1:2022) is conducted on a co-rotating twin-screw extruder with L/D ratio 44:1 (Coperion ZSK Mc18). The stabilizer premix—consisting of 0.15 phr of the triazolo-benzothiazole HALS, 0.05 phr of tris(2,4-di-tert-butylphenyl)phosphite (processing stabilizer, Irgafos 168), and 0.10 phr of calcium stearate as acid scavenger—is tumble-blended and fed via a gravimetric feeder at barrel zone 1. Processing temperatures from zone 2 through the strand die range from 190 °C to 220 °C; melt temperature at the die must not exceed 235 °C because thermogravimetric analysis under nitrogen shows a 2% weight loss onset at 242 °C for this specific heterocyclic derivative. Extruded pellets are injection-molded into tensile bars (ASTM D638-14 Type I) for weathering validation. Accelerated UV exposure per ASTM G154 Cycle 1 (UVA-340 lamp, 0.89 W/m² at 340 nm, 8 hours UV at 60 °C alternating with 4 hours condensation at 50 °C) reveals that the presence of the triazolo ring retards carbonyl development (FTIR peak at 1715 cm⁻¹) to 0.05 absorbance units after 3000 hours, compared to 0.25 units for an unstabilized control. Nevertheless, a pronounced antagonism has been observed when this compound is combined with monomeric benzotriazole UV absorbers at a 1:1 weight ratio; the carbonyl index increases unexpectedly by 40% compared to the HALS alone, likely due to exciplex formation that deactivates the nitroxyl radical regeneration cycle. Consequently, formulation guidance strictly advises against co-formulation with hydroxyphenyl-benzotriazole absorbers unless a synergistic screening study demonstrates net benefit.

In silicone-based sealants (neutral-cure oxime system, RTV-1), the triazolo-benzothiazole HALS is predissolved in a silicone oil carrier (100 cSt polydimethylsiloxane) at 10% w/w and dosed at 0.5–1.0% of the total formulation. Migration kinetics in cured silicone joints, as studied by confocal Raman microscopy with a 50 µm spatial resolution, show negligible depletion (<5% loss) from the bulk after 1000 hours at 70 °C in forced-air ovens, attributable to the higher molecular weight (> 600 g/mol) of the piperidine-substituted triazolo-benzothiazole compared to conventional bis(2,2,6,6-tetramethyl-4-piperidyl) sebacate. Outdoor exposure in a south Florida subtropical test site (ISO 877-1:2009 Method A, 5° direct exposure) over 60 months confirms retention of ≥80% of the original elongation at break, while a HALS-free control fails by 18 months due to surface chalking and modulus increase.

When N-Methyl-2-pyrrolidone Carrier Fluids Dominate Electroless Copper Baths

In printed circuit board fabrication, the compound serves as a specific brightener and grain refiner in electroless copper plating baths designed for high-aspect-ratio through-holes (> 10:1). The plating solution operates at pH 12.5–13.0 with sodium hydroxide as the pH adjuster, 0.04 M copper sulfate pentahydrate, 0.12 M formaldehyde as the reducing agent, and EDTA tetrasodium salt as the primary complexing agent. The methyl-1,2,4-triazolo[3,4-b]benzo-1,3-thiazole is introduced from a pre-dissolved stock solution in N-methyl-2-pyrrolidone (NMP) at a concentration of 2–5 mg/L of working bath. Its exact role is dual: adsorption onto active copper (111) crystal faces retards lateral growth while allowing normal growth, producing a fine equiaxed grain structure with an average crystallite size of 0.5–1.0 µm (determined by XRD Scherrer analysis on the 111 reflection at 2θ = 43.3°). Without this brightener, the deposit tends to develop columnar grains that reduce ductility and increase the risk of barrel cracking under thermal shock (IPC-TM-650 method 2.6.8, 288 °C solder float for 10 seconds).

Bath maintenance hinges on cyclic voltammetric stripping (CVS) measurements performed at 25 ± 0.5 °C with a platinum rotating disk electrode (2000 rpm). The brightener concentration is correlated with the suppression of the copper deposition peak at -0.25 V vs. Ag/AgCl. Tight control within 2–5 mg/L is mandatory; concentrations below 1.5 mg/L fail to suppress nodular growth at high-current-density edges (current density > 2.5 A/dm²), while concentrations above 8 mg/L cause excessive organic co-deposition and reduce tensile strength of the plated copper foil to below 300 MPa (IPC-4562 Class 3 requirement is ≥248 MPa per ASTM E345-16). A particular failure mode documented on horizontal electroless copper lines is the accumulation of formate byproduct from formaldehyde oxidation, which competes with the triazolo-benzothiazole for adsorption sites. When formate exceeds 15 g/L, the brightener becomes ineffective and must be replenished at double the normal rate, triggering an operational decision to either bleed the bath (10% v/v) or install an electrodialysis unit.

Environmental compliance for the plating line is driven by the EU RoHS Directive (2011/65/EU) which excludes these films from restriction, but waste treatment must address the chelate-stabilized copper and organic NMP content. Standard precipitation with calcium oxide to pH 10.5 and subsequent filtration through a plate-and-frame filter press with 5 µm polypropylene cloth fails to remove the dissolved heterocyclic brightener, which persists in the effluent at 0.3 mg/L. Advanced oxidation using Fenton’s reagent (hydrogen peroxide 500 ppm, ferrous sulfate 250 ppm, UV-C irradiation at 254 nm, 60 minutes contact time) achieves 97% degradation, enabling discharge compliance under local sewer use bylaws typically requiring Total Organic Carbon below 200 mg/L.

Closed recirculating cooling systems with copper heat exchangers benefit from the superior film persistency of the triazolo-benzothiazole-derived inhibitor compared with the industry-standard benzotriazole. Potentiodynamic polarization scans in aerated synthetic cooling water (250 mg/L CaCO₃ hardness, 150 mg/L Cl⁻, pH 8.2) at 40 °C show that while benzotriazole films desorb within 72 hours after inhibitor dosing ceases (corrosion rate rises to 3.2 mpy), the methyl-triazolo-benzothiazole film maintains a corrosion rate below 0.8 mpy for over 200 hours under identical conditions. This persistence arises from a bidentate coordination involving both the thiazole sulfur and the triazole N2 nitrogen, as inferred from Raman spectroscopy peaks at 290 cm⁻¹ (Cu-S stretch) and 520 cm⁻¹ (Cu-N stretch). In practice, a continuous feed of 25–50 mg/L is maintained by a positive-displacement metering pump linked to a corrosion coupon rack. Mass loss coupons (pre-weighed CDA 110 copper, 25 mm × 50 mm × 1.5 mm) removed every 30 days must show uniform corrosion rates below 0.5 mpy to satisfy the facility’s ASME PCC-2 repair records. Operating above 50 mg/L offers negligible incremental benefit but increases the risk of forming insoluble copper-inhibitor complexes with high-conductivity makeup water, fouling downstream sensors.

Registered users of this heterocyclic intermediate under EU REACH must report the dye as a substance in articles if its concentration exceeds 0.1% w/w in the final textile and the total imported volume exceeds 1 tonne/annum. Supporting documentation requires a Deriving No-Effect Level (DNEL) for dermal exposure; published data for this specific configuration is limited, necessitating a read-across argument from structurally similar benzothiazole azo dyes with oral DNEL values in the range of 0.5 mg/kg bw/day.